Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-7 of  7 نتائج ل ""CHINA studies""

فلترة النتائج

Publication : annals of oncology فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

402P Phase I study of selumetinib in Chinese pediatric and adult patients (pts) with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN): Interim results.

Subjects: *NEUROFIBROMATOSIS 1; *CHINA studies

  • Source: Annals of Oncology. Nov2022 Suppl 9, Vol. 33, pS1599-S1599. 1p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

108P A comprehensive pan-cancer study of fusions in Chinese cancer patients.

Subjects: *CANCER patients; *CHINA studies

  • Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS402-S403. 2p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

LBA20Keynote-407 China Extension study: Pembrolizumab (pembro) plus chemotherapy in Chinese patients with metastatic squamous NSCLC.

Subjects: *PART-time employment; *CHINA studies; *STOCK optionsCHINA

  • Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC).

Subjects: *CHINESE people; *OVARIAN cancer; *CHINA studies

  • Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS619-S620. 2p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

123P Long term survival analysis of osimertinib in stage IV NSCLC patients harbored acquired EGFR T790M mutation: A real-word study in China.

Subjects: *SURVIVAL analysis (Biometry); *NON-small-cell lung carcinoma; *EPIDERMAL growth factor receptorsCHINA

  • Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

1295P Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFR mutated (EGFRm) advanced NSCLC: FLAURA China study overall survival (OS).

Subjects: *OVERALL survival; *EPIDERMAL growth factor receptors; *KINASE inhibitors

  • Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS838-S839. 2p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

1146P Rh-endostatin combined with chemotherapy and interferon in the treatment of oral mucosal melanoma without clinical cervical lymph node metastasis: A retrospective study in Chinese population.

Subjects: *ORAL drug administration; *LYMPHATIC metastasis; *CHINESE people

  • Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS765-S765. 1p.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-7 of  7 نتائج ل ""CHINA studies""